Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 253-575-7
CAS number: 37640-57-6
the oral coadministration of 1 mg/kg body weight of melamine and
cyanuric acid did not alter significantly the pharmacokinetic profiles
in relation to those determined upon individual oral administration of
each compound, the administration of equal amounts of each triazine as
the preformed melamine cyanurate complex significantly altered the
pharmacokinetics, with reduced bioavailability of both compounds, lower
observed maximum serum concentrations, delayed peak concentrations, and
prolonged elimination half lives.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again